DISPARATE ACTIONS OF HYDROXYUREA IN POTENTIATION OF PURINE AND PYRIMIDINE 2',3'-DIDEOXYNUCLEOSIDE ACTIVITIES AGAINST REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS

被引:70
作者
GAO, WY [1 ]
JOHNS, DG [1 ]
CHOKEKIJCHAI, S [1 ]
MITSUYA, H [1 ]
机构
[1] NCI,DEV THERAPEUT PROGRAM,MED CHEM LAB,BETHESDA,MD 20892
关键词
D O I
10.1073/pnas.92.18.8333
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We and other groups have recently reported the potentiation by ribonucleotide reductase inhibitors such as hydroxyurea of the anti-human immunodeficiency virus type 1 (HIV-1) activity of purine and pyrimidine 2',3'-dideoxynucleosides in both resting and phytohemagglutinin-stimulated peripheral blood mononuclear cells. Little agreement prevails, however, as to the mechanism of the synergistic effects described. We report here that in phytophemagglutinin-stimulated peripheral blood mononuclear cells, two mechanisms exist for the potentiation of the anti-HIV-1 activity by low-dose hydroxyurea of the purine-based dideoxynucleoside 2',3'-dideoxyinosine and the pyrimidine-based dideoxynucleosides 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine. For 2',3'-dideoxyinosine, the enhancement arises from a specific depletion of dATP by hydroxyurea, resulting in a favorable shift of the 2',3'-dideoxyadenosine 5'-triphosphate/dATP ratio. For the pyrimidine dideoxynucleosides 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine, the more modest anti-HIV enhancement results from hydroxyurea-induced increases of pyrimidine kinase activities in the salvage pathway and, hence, increased 5'-phosphorylation of these drugs, while depletion of the corresponding deoxynucleoside 5'-triphosphates (dTTP and dCTP) plays no significant role.
引用
收藏
页码:8333 / 8337
页数:5
相关论文
共 26 条
[1]   INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY 2'-SUBSTITUTED DEOXYCYTIDINE ANALOGS - POSSIBLE APPLICATION IN AIDS TREATMENT [J].
BIANCHI, V ;
BORELLA, S ;
CALDERAZZO, F ;
FERRARO, P ;
BIANCHI, LC ;
REICHARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8403-8407
[2]  
BIANCHI V, 1986, J BIOL CHEM, V261, P6037
[3]   PERIODICITY OF DNA SYNTHETIC ENZYMES DURING HELA CELL CYCLE [J].
BRENT, TP .
CELL AND TISSUE KINETICS, 1971, 4 (04) :297-&
[4]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[5]   PROPERTIES AND LEVELS OF DEOXYNUCLEOSIDE KINASES IN NORMAL AND TUMOR-CELLS - IMPLICATIONS FOR CHEMOTHERAPY [J].
ERIKSSON, S ;
ARNER, E ;
SPASOKOUKOTSKAJA, T ;
WANG, LY ;
KARLSSON, A ;
BROSJO, O ;
GUNVEN, P ;
JULUSSON, G ;
LILIEMARK, J .
ADVANCES IN ENZYME REGULATION, VOL 34, 1994, 34 :13-25
[6]   ENZYMATIC ASSAY FOR QUANTIFICATION OF DEOXYNUCLEOSIDE TRIPHOSPHATES IN HUMAN-CELLS EXPOSED TO ANTIRETROVIRAL 2',3'-DIDEOXYNUCLEOSIDES [J].
GAO, WY ;
JOHNS, DG ;
MITSUYA, H .
ANALYTICAL BIOCHEMISTRY, 1994, 222 (01) :116-122
[7]   DIFFERENTIAL PHOSPHORYLATION OF AZIDOTHYMIDINE, DIDEOXYCYTIDINE, AND DIDEOXYINOSINE IN RESTING AND ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
GAO, WY ;
SHIRASAKA, T ;
JOHNS, DG ;
BRODER, S ;
MITSUYA, H .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2326-2333
[8]   LOW-LEVELS OF DEOXYNUCLEOTIDES IN PERIPHERAL-BLOOD LYMPHOCYTES - A STRATEGY TO INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION [J].
GAO, WY ;
CARA, A ;
GALLO, RC ;
LORI, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8925-8928
[9]  
GAO WY, 1994, MOL PHARMACOL, V46, P767
[10]   KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) DNA AND RNA-SYNTHESIS DURING PRIMARY HIV-1 INFECTION [J].
GRAZIOSI, C ;
PANTALEO, G ;
BUTINI, L ;
DEMAREST, JF ;
SAAG, MS ;
SHAW, GM ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6405-6409